Hemostasis
Title
Date Published
Tranexamic Acid Reduces Allogenic Transfusion in Revision Hip Arthroplasty.
June 24, 2010
Development of a rapid emergency hemorrhage panel.
June 21, 2010
Evaluation of a post-operative thrombin inhibitor replacement protocol to reduce haemorrhagic and thrombotic complications after paediatric liver transplantation.
June 11, 2010
The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty.
June 9, 2010
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.
June 3, 2010
Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery.
June 2, 2010
A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
June 1, 2010
Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients.
June 1, 2010
Adverse drug events associated with disorders of coagulation.
June 1, 2010
Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients.
May 31, 2010
Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia.
May 11, 2010
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
May 5, 2010
Optimizing on-demand treatment with NovoSeven room temperature stable.
May 1, 2010
Meeting unmet needs in inhibitor patients.
May 1, 2010
Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
April 28, 2010
Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes.
April 14, 2010
Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma – a rare indication for recombinant factor VIIa.
April 12, 2010
A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery.
April 6, 2010
Rate of inhibitor development in previously-untreated hemophilia a patients treated with plasma-derived or recombinant factor VIII concentrates. A systematic review.
March 16, 2010
Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand’s disease: a prospective multi-centre study.
March 16, 2010